Global Oncology Based In-vivo CRO Market Size, Status and Forecast 2020-2026

May 2020 | 93 pages | ID: G56C0F676923EN
QYResearch

Abstracts

This report focuses on the global Oncology Based In-vivo CRO status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncology Based In-vivo CRO development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Crown Bioscience
• Charles River Laboratory
• ICON Plc.
• Eurofins Scientific
• Taconic Biosciences
• Covance
• EVOTEC
• The Jackson Laboratory
• Wuxi AppTec.
• MI Bioresearch, Inc.
• Living Tumor Laboratory
• Champion Oncology, Inc.
• Xentech

Market segment by Type, the product can be split into

• Blood cancer
• Solid tumors
• Other

Market segment by Application, split into

• Hospitals
• Rehabilitation Centers
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Oncology Based In-vivo CRO status, future forecast, growth opportunity, key market and key players.
• To present the Oncology Based In-vivo CRO development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Oncology Based In-vivo CRO are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oncology Based In-vivo CRO Revenue
1.4 Market Analysis by Type
  1.4.1 Global Oncology Based In-vivo CRO Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Blood cancer
  1.4.3 Solid tumors
  1.4.4 Other
1.5 Market by Application
  1.5.1 Global Oncology Based In-vivo CRO Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Rehabilitation Centers
  1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Oncology Based In-vivo CRO Market Perspective (2015-2026)
2.2 Oncology Based In-vivo CRO Growth Trends by Regions
  2.2.1 Oncology Based In-vivo CRO Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Oncology Based In-vivo CRO Historic Market Share by Regions (2015-2020)
  2.2.3 Oncology Based In-vivo CRO Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Oncology Based In-vivo CRO Market Growth Strategy
  2.3.6 Primary Interviews with Key Oncology Based In-vivo CRO Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Oncology Based In-vivo CRO Players by Market Size
  3.1.1 Global Top Oncology Based In-vivo CRO Players by Revenue (2015-2020)
  3.1.2 Global Oncology Based In-vivo CRO Revenue Market Share by Players (2015-2020)
  3.1.3 Global Oncology Based In-vivo CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Oncology Based In-vivo CRO Market Concentration Ratio
  3.2.1 Global Oncology Based In-vivo CRO Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Oncology Based In-vivo CRO Revenue in 2019
3.3 Oncology Based In-vivo CRO Key Players Head office and Area Served
3.4 Key Players Oncology Based In-vivo CRO Product Solution and Service
3.5 Date of Enter into Oncology Based In-vivo CRO Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Oncology Based In-vivo CRO Historic Market Size by Type (2015-2020)
4.2 Global Oncology Based In-vivo CRO Forecasted Market Size by Type (2021-2026)

5 ONCOLOGY BASED IN-VIVO CRO BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Oncology Based In-vivo CRO Market Size by Application (2015-2020)
5.2 Global Oncology Based In-vivo CRO Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Oncology Based In-vivo CRO Market Size (2015-2020)
6.2 Oncology Based In-vivo CRO Key Players in North America (2019-2020)
6.3 North America Oncology Based In-vivo CRO Market Size by Type (2015-2020)
6.4 North America Oncology Based In-vivo CRO Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Oncology Based In-vivo CRO Market Size (2015-2020)
7.2 Oncology Based In-vivo CRO Key Players in Europe (2019-2020)
7.3 Europe Oncology Based In-vivo CRO Market Size by Type (2015-2020)
7.4 Europe Oncology Based In-vivo CRO Market Size by Application (2015-2020)

8 CHINA

8.1 China Oncology Based In-vivo CRO Market Size (2015-2020)
8.2 Oncology Based In-vivo CRO Key Players in China (2019-2020)
8.3 China Oncology Based In-vivo CRO Market Size by Type (2015-2020)
8.4 China Oncology Based In-vivo CRO Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Oncology Based In-vivo CRO Market Size (2015-2020)
9.2 Oncology Based In-vivo CRO Key Players in Japan (2019-2020)
9.3 Japan Oncology Based In-vivo CRO Market Size by Type (2015-2020)
9.4 Japan Oncology Based In-vivo CRO Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Oncology Based In-vivo CRO Market Size (2015-2020)
10.2 Oncology Based In-vivo CRO Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Oncology Based In-vivo CRO Market Size by Type (2015-2020)
10.4 Southeast Asia Oncology Based In-vivo CRO Market Size by Application (2015-2020)

11 INDIA

11.1 India Oncology Based In-vivo CRO Market Size (2015-2020)
11.2 Oncology Based In-vivo CRO Key Players in India (2019-2020)
11.3 India Oncology Based In-vivo CRO Market Size by Type (2015-2020)
11.4 India Oncology Based In-vivo CRO Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Oncology Based In-vivo CRO Market Size (2015-2020)
12.2 Oncology Based In-vivo CRO Key Players in Central & South America (2019-2020)
12.3 Central & South America Oncology Based In-vivo CRO Market Size by Type (2015-2020)
12.4 Central & South America Oncology Based In-vivo CRO Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Crown Bioscience
  13.1.1 Crown Bioscience Company Details
  13.1.2 Crown Bioscience Business Overview and Its Total Revenue
  13.1.3 Crown Bioscience Oncology Based In-vivo CRO Introduction
  13.1.4 Crown Bioscience Revenue in Oncology Based In-vivo CRO Business (2015-2020))
  13.1.5 Crown Bioscience Recent Development
13.2 Charles River Laboratory
  13.2.1 Charles River Laboratory Company Details
  13.2.2 Charles River Laboratory Business Overview and Its Total Revenue
  13.2.3 Charles River Laboratory Oncology Based In-vivo CRO Introduction
  13.2.4 Charles River Laboratory Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  13.2.5 Charles River Laboratory Recent Development
13.3 ICON Plc.
  13.3.1 ICON Plc. Company Details
  13.3.2 ICON Plc. Business Overview and Its Total Revenue
  13.3.3 ICON Plc. Oncology Based In-vivo CRO Introduction
  13.3.4 ICON Plc. Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  13.3.5 ICON Plc. Recent Development
13.4 Eurofins Scientific
  13.4.1 Eurofins Scientific Company Details
  13.4.2 Eurofins Scientific Business Overview and Its Total Revenue
  13.4.3 Eurofins Scientific Oncology Based In-vivo CRO Introduction
  13.4.4 Eurofins Scientific Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  13.4.5 Eurofins Scientific Recent Development
13.5 Taconic Biosciences
  13.5.1 Taconic Biosciences Company Details
  13.5.2 Taconic Biosciences Business Overview and Its Total Revenue
  13.5.3 Taconic Biosciences Oncology Based In-vivo CRO Introduction
  13.5.4 Taconic Biosciences Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  13.5.5 Taconic Biosciences Recent Development
13.6 Covance
  13.6.1 Covance Company Details
  13.6.2 Covance Business Overview and Its Total Revenue
  13.6.3 Covance Oncology Based In-vivo CRO Introduction
  13.6.4 Covance Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  13.6.5 Covance Recent Development
13.7 EVOTEC
  13.7.1 EVOTEC Company Details
  13.7.2 EVOTEC Business Overview and Its Total Revenue
  13.7.3 EVOTEC Oncology Based In-vivo CRO Introduction
  13.7.4 EVOTEC Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  13.7.5 EVOTEC Recent Development
13.8 The Jackson Laboratory
  13.8.1 The Jackson Laboratory Company Details
  13.8.2 The Jackson Laboratory Business Overview and Its Total Revenue
  13.8.3 The Jackson Laboratory Oncology Based In-vivo CRO Introduction
  13.8.4 The Jackson Laboratory Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  13.8.5 The Jackson Laboratory Recent Development
13.9 Wuxi AppTec.
  13.9.1 Wuxi AppTec. Company Details
  13.9.2 Wuxi AppTec. Business Overview and Its Total Revenue
  13.9.3 Wuxi AppTec. Oncology Based In-vivo CRO Introduction
  13.9.4 Wuxi AppTec. Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  13.9.5 Wuxi AppTec. Recent Development
13.10 MI Bioresearch, Inc.
  13.10.1 MI Bioresearch, Inc. Company Details
  13.10.2 MI Bioresearch, Inc. Business Overview and Its Total Revenue
  13.10.3 MI Bioresearch, Inc. Oncology Based In-vivo CRO Introduction
  13.10.4 MI Bioresearch, Inc. Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  13.10.5 MI Bioresearch, Inc. Recent Development
13.11 Living Tumor Laboratory
  10.11.1 Living Tumor Laboratory Company Details
  10.11.2 Living Tumor Laboratory Business Overview and Its Total Revenue
  10.11.3 Living Tumor Laboratory Oncology Based In-vivo CRO Introduction
  10.11.4 Living Tumor Laboratory Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  10.11.5 Living Tumor Laboratory Recent Development
13.12 Champion Oncology, Inc.
  10.12.1 Champion Oncology, Inc. Company Details
  10.12.2 Champion Oncology, Inc. Business Overview and Its Total Revenue
  10.12.3 Champion Oncology, Inc. Oncology Based In-vivo CRO Introduction
  10.12.4 Champion Oncology, Inc. Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  10.12.5 Champion Oncology, Inc. Recent Development
13.13 Xentech
  10.13.1 Xentech Company Details
  10.13.2 Xentech Business Overview and Its Total Revenue
  10.13.3 Xentech Oncology Based In-vivo CRO Introduction
  10.13.4 Xentech Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  10.13.5 Xentech Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Oncology Based In-vivo CRO Key Market Segments
Table 2. Key Players Covered: Ranking by Oncology Based In-vivo CRO Revenue
Table 3. Ranking of Global Top Oncology Based In-vivo CRO Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Oncology Based In-vivo CRO Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Blood cancer
Table 6. Key Players of Solid tumors
Table 7. Key Players of Other
Table 8. Global Oncology Based In-vivo CRO Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Oncology Based In-vivo CRO Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Oncology Based In-vivo CRO Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Oncology Based In-vivo CRO Market Share by Regions (2015-2020)
Table 12. Global Oncology Based In-vivo CRO Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Oncology Based In-vivo CRO Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Oncology Based In-vivo CRO Market Growth Strategy
Table 18. Main Points Interviewed from Key Oncology Based In-vivo CRO Players
Table 19. Global Oncology Based In-vivo CRO Revenue by Players (2015-2020) (Million US$)
Table 20. Global Oncology Based In-vivo CRO Market Share by Players (2015-2020)
Table 21. Global Top Oncology Based In-vivo CRO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Based In-vivo CRO as of 2019)
Table 22. Global Oncology Based In-vivo CRO by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Oncology Based In-vivo CRO Product Solution and Service
Table 25. Date of Enter into Oncology Based In-vivo CRO Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oncology Based In-vivo CRO Market Size by Type (2015-2020) (Million US$)
Table 28. Global Oncology Based In-vivo CRO Market Size Share by Type (2015-2020)
Table 29. Global Oncology Based In-vivo CRO Revenue Market Share by Type (2021-2026)
Table 30. Global Oncology Based In-vivo CRO Market Size Share by Application (2015-2020)
Table 31. Global Oncology Based In-vivo CRO Market Size by Application (2015-2020) (Million US$)
Table 32. Global Oncology Based In-vivo CRO Market Size Share by Application (2021-2026)
Table 33. North America Key Players Oncology Based In-vivo CRO Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Oncology Based In-vivo CRO Market Share (2019-2020)
Table 35. North America Oncology Based In-vivo CRO Market Size by Type (2015-2020) (Million US$)
Table 36. North America Oncology Based In-vivo CRO Market Share by Type (2015-2020)
Table 37. North America Oncology Based In-vivo CRO Market Size by Application (2015-2020) (Million US$)
Table 38. North America Oncology Based In-vivo CRO Market Share by Application (2015-2020)
Table 39. Europe Key Players Oncology Based In-vivo CRO Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Oncology Based In-vivo CRO Market Share (2019-2020)
Table 41. Europe Oncology Based In-vivo CRO Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Oncology Based In-vivo CRO Market Share by Type (2015-2020)
Table 43. Europe Oncology Based In-vivo CRO Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Oncology Based In-vivo CRO Market Share by Application (2015-2020)
Table 45. China Key Players Oncology Based In-vivo CRO Revenue (2019-2020) (Million US$)
Table 46. China Key Players Oncology Based In-vivo CRO Market Share (2019-2020)
Table 47. China Oncology Based In-vivo CRO Market Size by Type (2015-2020) (Million US$)
Table 48. China Oncology Based In-vivo CRO Market Share by Type (2015-2020)
Table 49. China Oncology Based In-vivo CRO Market Size by Application (2015-2020) (Million US$)
Table 50. China Oncology Based In-vivo CRO Market Share by Application (2015-2020)
Table 51. Japan Key Players Oncology Based In-vivo CRO Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Oncology Based In-vivo CRO Market Share (2019-2020)
Table 53. Japan Oncology Based In-vivo CRO Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Oncology Based In-vivo CRO Market Share by Type (2015-2020)
Table 55. Japan Oncology Based In-vivo CRO Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Oncology Based In-vivo CRO Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Oncology Based In-vivo CRO Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Oncology Based In-vivo CRO Market Share (2019-2020)
Table 59. Southeast Asia Oncology Based In-vivo CRO Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Oncology Based In-vivo CRO Market Share by Type (2015-2020)
Table 61. Southeast Asia Oncology Based In-vivo CRO Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Oncology Based In-vivo CRO Market Share by Application (2015-2020)
Table 63. India Key Players Oncology Based In-vivo CRO Revenue (2019-2020) (Million US$)
Table 64. India Key Players Oncology Based In-vivo CRO Market Share (2019-2020)
Table 65. India Oncology Based In-vivo CRO Market Size by Type (2015-2020) (Million US$)
Table 66. India Oncology Based In-vivo CRO Market Share by Type (2015-2020)
Table 67. India Oncology Based In-vivo CRO Market Size by Application (2015-2020) (Million US$)
Table 68. India Oncology Based In-vivo CRO Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Oncology Based In-vivo CRO Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Oncology Based In-vivo CRO Market Share (2019-2020)
Table 71. Central & South America Oncology Based In-vivo CRO Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Oncology Based In-vivo CRO Market Share by Type (2015-2020)
Table 73. Central & South America Oncology Based In-vivo CRO Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Oncology Based In-vivo CRO Market Share by Application (2015-2020)
Table 75. Crown Bioscience Company Details
Table 76. Crown Bioscience Business Overview
Table 77. Crown Bioscience Product
Table 78. Crown Bioscience Revenue in Oncology Based In-vivo CRO Business (2015-2020) (Million US$)
Table 79. Crown Bioscience Recent Development
Table 80. Charles River Laboratory Company Details
Table 81. Charles River Laboratory Business Overview
Table 82. Charles River Laboratory Product
Table 83. Charles River Laboratory Revenue in Oncology Based In-vivo CRO Business (2015-2020) (Million US$)
Table 84. Charles River Laboratory Recent Development
Table 85. ICON Plc. Company Details
Table 86. ICON Plc. Business Overview
Table 87. ICON Plc. Product
Table 88. ICON Plc. Revenue in Oncology Based In-vivo CRO Business (2015-2020) (Million US$)
Table 89. ICON Plc. Recent Development
Table 90. Eurofins Scientific Company Details
Table 91. Eurofins Scientific Business Overview
Table 92. Eurofins Scientific Product
Table 93. Eurofins Scientific Revenue in Oncology Based In-vivo CRO Business (2015-2020) (Million US$)
Table 94. Eurofins Scientific Recent Development
Table 95. Taconic Biosciences Company Details
Table 96. Taconic Biosciences Business Overview
Table 97. Taconic Biosciences Product
Table 98. Taconic Biosciences Revenue in Oncology Based In-vivo CRO Business (2015-2020) (Million US$)
Table 99. Taconic Biosciences Recent Development
Table 100. Covance Company Details
Table 101. Covance Business Overview
Table 102. Covance Product
Table 103. Covance Revenue in Oncology Based In-vivo CRO Business (2015-2020) (Million US$)
Table 104. Covance Recent Development
Table 105. EVOTEC Company Details
Table 106. EVOTEC Business Overview
Table 107. EVOTEC Product
Table 108. EVOTEC Revenue in Oncology Based In-vivo CRO Business (2015-2020) (Million US$)
Table 109. EVOTEC Recent Development
Table 110. The Jackson Laboratory Business Overview
Table 111. The Jackson Laboratory Product
Table 112. The Jackson Laboratory Company Details
Table 113. The Jackson Laboratory Revenue in Oncology Based In-vivo CRO Business (2015-2020) (Million US$)
Table 114. The Jackson Laboratory Recent Development
Table 115. Wuxi AppTec. Company Details
Table 116. Wuxi AppTec. Business Overview
Table 117. Wuxi AppTec. Product
Table 118. Wuxi AppTec. Revenue in Oncology Based In-vivo CRO Business (2015-2020) (Million US$)
Table 119. Wuxi AppTec. Recent Development
Table 120. MI Bioresearch, Inc. Company Details
Table 121. MI Bioresearch, Inc. Business Overview
Table 122. MI Bioresearch, Inc. Product
Table 123. MI Bioresearch, Inc. Revenue in Oncology Based In-vivo CRO Business (2015-2020) (Million US$)
Table 124. MI Bioresearch, Inc. Recent Development
Table 125. Living Tumor Laboratory Company Details
Table 126. Living Tumor Laboratory Business Overview
Table 127. Living Tumor Laboratory Product
Table 128. Living Tumor Laboratory Revenue in Oncology Based In-vivo CRO Business (2015-2020) (Million US$)
Table 129. Living Tumor Laboratory Recent Development
Table 130. Champion Oncology, Inc. Company Details
Table 131. Champion Oncology, Inc. Business Overview
Table 132. Champion Oncology, Inc. Product
Table 133. Champion Oncology, Inc. Revenue in Oncology Based In-vivo CRO Business (2015-2020) (Million US$)
Table 134. Champion Oncology, Inc. Recent Development
Table 135. Xentech Company Details
Table 136. Xentech Business Overview
Table 137. Xentech Product
Table 138. Xentech Revenue in Oncology Based In-vivo CRO Business (2015-2020) (Million US$)
Table 139. Xentech Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Oncology Based In-vivo CRO Market Share by Type: 2020 VS 2026
Figure 2. Blood cancer Features
Figure 3. Solid tumors Features
Figure 4. Other Features
Figure 5. Global Oncology Based In-vivo CRO Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Rehabilitation Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Oncology Based In-vivo CRO Report Years Considered
Figure 10. Global Oncology Based In-vivo CRO Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Oncology Based In-vivo CRO Market Share by Regions: 2020 VS 2026
Figure 12. Global Oncology Based In-vivo CRO Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Oncology Based In-vivo CRO Market Share by Players in 2019
Figure 15. Global Top Oncology Based In-vivo CRO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Based In-vivo CRO as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Oncology Based In-vivo CRO Revenue in 2019
Figure 17. North America Oncology Based In-vivo CRO Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Oncology Based In-vivo CRO Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Oncology Based In-vivo CRO Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Oncology Based In-vivo CRO Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Oncology Based In-vivo CRO Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Oncology Based In-vivo CRO Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Oncology Based In-vivo CRO Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Crown Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Crown Bioscience Revenue Growth Rate in Oncology Based In-vivo CRO Business (2015-2020)
Figure 26. Charles River Laboratory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Charles River Laboratory Revenue Growth Rate in Oncology Based In-vivo CRO Business (2015-2020)
Figure 28. ICON Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. ICON Plc. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2015-2020)
Figure 30. Eurofins Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Eurofins Scientific Revenue Growth Rate in Oncology Based In-vivo CRO Business (2015-2020)
Figure 32. Taconic Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Taconic Biosciences Revenue Growth Rate in Oncology Based In-vivo CRO Business (2015-2020)
Figure 34. Covance Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Covance Revenue Growth Rate in Oncology Based In-vivo CRO Business (2015-2020)
Figure 36. EVOTEC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. EVOTEC Revenue Growth Rate in Oncology Based In-vivo CRO Business (2015-2020)
Figure 38. The Jackson Laboratory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. The Jackson Laboratory Revenue Growth Rate in Oncology Based In-vivo CRO Business (2015-2020)
Figure 40. Wuxi AppTec. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Wuxi AppTec. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2015-2020)
Figure 42. MI Bioresearch, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. MI Bioresearch, Inc. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2015-2020)
Figure 44. Living Tumor Laboratory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Living Tumor Laboratory Revenue Growth Rate in Oncology Based In-vivo CRO Business (2015-2020)
Figure 46. Champion Oncology, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Champion Oncology, Inc. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2015-2020)
Figure 48. Xentech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Xentech Revenue Growth Rate in Oncology Based In-vivo CRO Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed